Mettler-Toledo International (NYSE:MTD) Issues Q4 2025 Earnings Guidance

Mettler-Toledo International (NYSE:MTD) issued an update on its fourth quarter 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 12.680-12.880 for the period, compared to the consensus estimate of 13.120. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion. Mettler-Toledo International also updated its FY 2025 guidance to 42.050-42.250 EPS.

Mettler-Toledo International Price Performance

Shares of Mettler-Toledo International stock traded up $2.69 during trading hours on Thursday, reaching $1,442.42. The company had a trading volume of 210,956 shares, compared to its average volume of 165,587. Mettler-Toledo International has a one year low of $946.69 and a one year high of $1,454.68. The business has a fifty day simple moving average of $1,314.61 and a 200 day simple moving average of $1,230.51. The firm has a market cap of $29.71 billion, a PE ratio of 36.53, a price-to-earnings-growth ratio of 4.19 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, topping analysts’ consensus estimates of $10.63 by $0.52. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. On average, research analysts forecast that Mettler-Toledo International will post 42.71 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on MTD shares. Robert W. Baird raised their price target on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. Barclays lifted their price objective on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an “overweight” rating in a research note on Thursday, October 2nd. Bank of America lifted their price objective on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research note on Monday, September 22nd. JPMorgan Chase & Co. lifted their price objective on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research note on Thursday, October 9th. Finally, Evercore ISI lifted their price objective on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a research note on Tuesday, October 7th. Five analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat, Mettler-Toledo International currently has a consensus rating of “Hold” and a consensus price target of $1,336.50.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, Director Thomas P. Salice sold 1,062 shares of Mettler-Toledo International stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the sale, the director owned 283 shares of the company’s stock, valued at $368,154.70. The trade was a 78.96% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total value of $397,500.00. Following the sale, the chief financial officer directly owned 5,095 shares of the company’s stock, valued at approximately $6,750,875. This trade represents a 5.56% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 1,827 shares of company stock valued at $2,371,208. Company insiders own 0.77% of the company’s stock.

Institutional Investors Weigh In On Mettler-Toledo International

Several hedge funds have recently added to or reduced their stakes in MTD. Geneos Wealth Management Inc. lifted its stake in Mettler-Toledo International by 83.3% during the first quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock worth $78,000 after purchasing an additional 30 shares during the last quarter. Baird Financial Group Inc. lifted its stake in Mettler-Toledo International by 3.1% during the second quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock worth $1,582,000 after purchasing an additional 40 shares during the last quarter. Jump Financial LLC lifted its stake in Mettler-Toledo International by 44.6% during the second quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock worth $476,000 after purchasing an additional 125 shares during the last quarter. Cerity Partners LLC lifted its stake in Mettler-Toledo International by 10.8% during the second quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock worth $4,740,000 after purchasing an additional 392 shares during the last quarter. Finally, AXA S.A. lifted its stake in Mettler-Toledo International by 2.9% during the second quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier’s stock worth $5,433,000 after purchasing an additional 131 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.